Skip to content
Filter :
EMBO molecular medicine
Metabolic diseases

CD38-NADase is a new major contributor to Duchenne muscular dystrophic phenotype

EMBO molecular medicine
Hematology

Single-domain antibodies targeting antithrombin reduce bleeding in hemophilic mice with or without inhibitors